Fanconi Anemia Complementation Group L Protein [protein FANCL]
topical
2
- Terms
-
FANCL Protein
Fanconi Anemia Group L Complementing Protein
Fanconi Anemia Group L Protein
PHD Finger Protein 9
Ubiquitin Ligase Protein PHF9
Persistent link
https://www.medvik.cz/link/D052240
Definition
An E3 UBIQUITIN LIGASE that plays a key role in the DNA damage response pathway of FANCONI ANEMIA PROTEINS. It is associated with mono-ubiquitination of FANCD2 PROTEIN and the redistribution of FANCD2 to nuclear foci containing BRCA1 PROTEIN.
- DUI
- D052240 MeSH Browser
- CUI
- M0483809
- History note
- 2006 (2003)
- Public note
- 2006; FANCONI ANEMIA COMPLEMENTATION GROUP L PROTEIN was indexed under LIGASES 2003-2005
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- DE
- drug effects
- EC
- economics
- GE
- genetics 2
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D08.811.464.938.750.257
Nedd4 Ubiquitin Protein Ligases
D08.811.464.938.750.703
Seven in Absentia Proteins
D08.811.464.938.750.782
Tripartite Motif-Containing Protein 28
D12.776.313.843
Fanconi Anemia Complementation Group E Protein
D12.776.313.875
Fanconi Anemia Complementation Group F Protein
FANCL protein, human Chemical MeSH Browser